Company Overview
About Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.
Business Model & Competitive Advantage
Emulate holds a uniquely strong regulatory relationship with the FDA: its Liver-Chip is the first and only Organ-Chip accepted into the FDA's ISTAND (Innovative Science and Technology Approaches for New Drugs) program for drug-induced liver injury (DILI) evaluation, and the agency has used Emulate chips to study the safety of COVID-19 therapeutics and vaccines. This FDA recognition reflects the broader regulatory shift announced by the agency to reduce mandatory animal testing in preclinical safety studies. In June 2025 Emulate launched the AVA™ Emulation System, a self-contained instrument capable of culturing and imaging up to 96 independent Organ-Chip samples simultaneously, cutting consumable costs four-fold and in-lab labor by half compared to prior iterations. The company has raised $82M in a 2021 Series E and has chips installed in more than 150 research facilities globally.
Competitive Landscape 2025–2026
Emulate's customer base includes 17 of the top 25 global biopharmaceutical companies, as well as academic medical centers, the FDA, the European Medicines Agency, and even the International Space Station for microgravity research. The company has expanded its technology platform with Brain-Chip R1 (launched November 2025 with FUJIFILM Cellular Dynamics) and the Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance biological modeling accuracy. As the regulatory momentum around New Approach Methodologies (NAMs) accelerates, Emulate is positioned as the reference platform for human-relevant preclinical safety and efficacy testing.
Key Differentiators
Market Leader
Emulate is recognized as a market leader in the Life Sciences & BioTech sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Saama Analytics
Saama Analytics is the leading AI-driven clinical analytics and data management platform for the life sciences industry, positioning itself as the "#1 in AI Clinical Analytics" based on customer adopt
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Compare Emulate with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Emulate? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Emulate Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Emulate vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →